disulfiram has been researched along with Substance Withdrawal Syndrome in 58 studies
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
Excerpt | Relevance | Reference |
---|---|---|
"The authors describe a case of the catatonia syndrome associated with disulfiram therapy." | 7.66 | Disulfiram encephalopathy as a cause of the catatonia syndrome. ( Marks, RC; Verghese, JP; Weddington, WW, 1980) |
"Disulfiram treatment for alcohol dependence is used with acceptable outcomes." | 5.40 | Disulfiram--alcohol reaction mimicking an acute coronary syndrome. ( Amuchastegui, M; Amuchastegui, T; Donohue, T, 2014) |
"The authors describe a case of the catatonia syndrome associated with disulfiram therapy." | 3.66 | Disulfiram encephalopathy as a cause of the catatonia syndrome. ( Marks, RC; Verghese, JP; Weddington, WW, 1980) |
"A 49-year-old female with chronic alcoholism and epilepsy, treated with phenytoin, began to convulse when treatment with disulfiram (an inhibitor of phenytoin metabolism) was discontinued." | 3.65 | Multiple drug interactions with phenytoin. ( Birkett, DJ; Chinwah, PM; Graham, GG; Hickie, JB; Wade, DN, 1977) |
"Prevalence of alcohol dependence remains stable across time between 5-7% in men and 2-3% in women, corresponding to at least 1." | 2.44 | [Alcohol dependence: diagnosis and treatment]. ( Blanc, F; Perney, P; Rigole, H, 2008) |
"Treatment of alcohol and drug addictions, which has been neglected medically for a long time, is currently sparked with optimism." | 2.40 | Rational treatment of addiction. ( Terenius, L, 1998) |
"Unfortunately, treatment of opioid dependence is difficult, particularly because of codependence - for example, on alcohol or other drugs of abuse." | 1.48 | Disulfiram attenuates morphine or methadone withdrawal syndrome in mice. ( Bujalska-Zadrożny, M; de Cordé, A; Filip, M; Kleczkowska, P; Krząścik, P; Wolińska, R, 2018) |
"Disulfiram treatment for alcohol dependence is used with acceptable outcomes." | 1.40 | Disulfiram--alcohol reaction mimicking an acute coronary syndrome. ( Amuchastegui, M; Amuchastegui, T; Donohue, T, 2014) |
"It has been shown that depakin, a GABA-ergic agonist, and alpha-methyl-DOPA that inhibits catecholamine synthesis are capable of removing the withdrawal syndrome (disturbed pavlovian behavior pattern and aggressiveness) occurring after discontinuance of long-term administration (30 days) of phenazepam to rats in a dose of 2 mg/kg." | 1.26 | [Role of GABA-ergic and dopaminergic mechanisms in the withdrawal syndrome after discontinuation of long-term phenazepam administration]. ( Garibova, TL; Voronina, TA, 1980) |
"Moderate withdrawal symptoms in susceptible patients require substitution medication which can be monitored on an outpatient basis." | 1.26 | Ambulatory management in alcoholism. ( Bort, RF, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (63.79) | 18.7374 |
1990's | 4 (6.90) | 18.2507 |
2000's | 5 (8.62) | 29.6817 |
2010's | 6 (10.34) | 24.3611 |
2020's | 6 (10.34) | 2.80 |
Authors | Studies |
---|---|
Chen, M | 1 |
Huang, Z | 1 |
Xia, M | 1 |
Ding, Y | 1 |
Shan, T | 1 |
Guan, Z | 1 |
Dai, X | 1 |
Xu, X | 1 |
Huang, Y | 1 |
Huang, M | 1 |
Zhao, C | 1 |
Pontzen, N | 1 |
Schomerus, G | 1 |
Steinberg, H | 1 |
Yuan, M | 1 |
Wu, Q | 1 |
Zhang, M | 1 |
Lai, M | 1 |
Chen, W | 1 |
Yang, J | 1 |
Jiang, L | 1 |
Cao, J | 1 |
Li, C | 1 |
Zhou, S | 1 |
Chen, C | 1 |
Zhu, L | 1 |
Li, S | 1 |
Song, Z | 1 |
Liang, J | 1 |
Tang, C | 1 |
Xu, N | 1 |
Liu, T | 1 |
Liu, S | 1 |
Balhara, YPS | 1 |
Singh, S | 1 |
Narang, P | 1 |
Kelty, E | 1 |
Terplan, M | 1 |
Greenland, M | 1 |
Preen, D | 1 |
de Cordé, A | 1 |
Krząścik, P | 1 |
Wolińska, R | 1 |
Kleczkowska, P | 1 |
Filip, M | 1 |
Bujalska-Zadrożny, M | 1 |
Douaihy, AB | 1 |
Kelly, TM | 1 |
Sullivan, C | 1 |
Amuchastegui, T | 1 |
Amuchastegui, M | 1 |
Donohue, T | 1 |
Ponizovskiy, PA | 1 |
Gofman, AG | 1 |
Maremmani, AG | 1 |
Pani, PP | 1 |
Rovai, L | 1 |
Pacini, M | 1 |
Dell'Osso, L | 1 |
Maremmani, I | 1 |
Clark, DB | 1 |
MANN, H | 1 |
CLANCY, J | 1 |
FOX, R | 1 |
Bailey, KP | 1 |
Diehl, A | 1 |
Mann, K | 1 |
Perney, P | 1 |
Rigole, H | 1 |
Blanc, F | 1 |
Guerri, C | 1 |
Grisolía, S | 1 |
Chan, AW | 1 |
Voronina, TA | 1 |
Garibova, TL | 1 |
Weddington, WW | 1 |
Marks, RC | 1 |
Verghese, JP | 1 |
Heinälä, P | 1 |
Sinclair, D | 1 |
Kiianmaa, K | 1 |
Sillanaukee, P | 1 |
Hayashida, M | 1 |
Miller, NS | 1 |
Smith, DE | 1 |
Terenius, L | 1 |
Bort, RF | 1 |
Edwards, G | 1 |
Kissin, B | 2 |
Birkett, DJ | 1 |
Graham, GG | 1 |
Chinwah, PM | 1 |
Wade, DN | 1 |
Hickie, JB | 1 |
Vendsborg, P | 1 |
Bueno, F | 1 |
Mezey, E | 1 |
Sytinsky, IA | 1 |
Gurevitch, ZP | 1 |
Hore, BD | 1 |
Coger, RW | 1 |
Dymond, AM | 1 |
Serafetinides, EA | 1 |
Lowenstam, I | 1 |
Pearson, D | 1 |
Boss, D | 1 |
Sauter, A | 1 |
Cornu, F | 1 |
Seixas, FA | 1 |
Goldfarb, C | 1 |
Hartman, B | 1 |
Shishov, VI | 1 |
Liskow, BI | 1 |
Goodwin, DW | 1 |
Gross, MM | 1 |
Oge, V | 1 |
Caldwell, J | 1 |
Sever, PS | 1 |
Feuerlein, W | 2 |
Schmidt, L | 2 |
Liebson, I | 1 |
Bigelow, G | 1 |
Flamer, R | 1 |
Tölle, R | 1 |
Gorecki, T | 1 |
Konarska, L | 1 |
Urakov, IG | 1 |
Mozias, MR | 1 |
Hussain, MZ | 1 |
Harinath, M | 1 |
Windischmann, H | 1 |
Tito, C | 1 |
Alberto, C | 1 |
Pietro, R | 1 |
Mattila, MJ | 1 |
Alhava, E | 1 |
Mansner, R | 1 |
Reimer, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Acamprosate for Central Nervous System Hyperexcitability and Neuroadaptation in Alcohol Withdrawal[NCT00106106] | Phase 2 | 56 participants (Actual) | Interventional | 2005-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The ratio of glutamate to creatine was determined using magnetic resonance spectroscopy (MRS), a technique that complements magnetic resonance imaging (MRI). MRS is used to determine the concentration of brain metabolites, such as glutamate, in brain tissue. MRS utilizes a magnetic field to look at magnetic nuclei, which absorb and re-emit electromagnetic energy in the presence of the magnetic field. By looking at the peaks in the resultant spectra the structure and concentration of metabolites can be determined. (NCT00106106)
Timeframe: Day 25
Intervention | Ratio of glutamate to creatine (Mean) |
---|---|
Placebo | 1.350375 |
Acamprosate | 1.166667 |
The ratio of glutamate to creatine was determined using magnetic resonance spectroscopy (MRS), a technique that complements magnetic resonance imaging (MRI). MRS is used to determine the concentration of brain metabolites, such as glutamate, in brain tissue. MRS utilizes a magnetic field to look at magnetic nuclei, which absorb and re-emit electromagnetic energy in the presence of the magnetic field. By looking at the peaks in the resultant spectra the structure and concentration of metabolites can be determined. (NCT00106106)
Timeframe: Day 4
Intervention | Ratio of glutamate to creatine (Mean) |
---|---|
Placebo | 1.256772 |
Acamprosate | 1.294178 |
15 reviews available for disulfiram and Substance Withdrawal Syndrome
Article | Year |
---|---|
Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
Topics: Acamprosate; Alcohol Abstinence; Alcohol Deterrents; Alcoholism; Animals; Comorbidity; Disulfiram; F | 2021 |
Medications for substance use disorders.
Topics: Alcohol Deterrents; Alcoholism; Analgesics, Opioid; Behavior Therapy; Behavior, Addictive; Buprenorp | 2013 |
[Depression in alcohol addicted patients].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Comorbidity; Depressive Disorder | 2015 |
Pharmacological treatments for substance use disorders.
Topics: Adrenergic beta-Antagonists; Alcohol Deterrents; Anti-Anxiety Agents; Benzodiazepines; Buprenorphine | 2004 |
[Pharmacological relapse prevention in alcohol and tobacco dependence].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Combined Modality Therapy; Di | 2007 |
[Alcohol dependence: diagnosis and treatment].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Cognitive Behavioral Therapy; Disulfiram; Humans; Motiv | 2008 |
Effects of combined alcohol and benzodiazepine: a review.
Topics: Abnormalities, Drug-Induced; Accidents, Traffic; Adolescent; Adult; Age Factors; Alcohol Drinking; A | 1984 |
[What is used as a drug for problem drinking?].
Topics: Alcohol Deterrents; Alcoholism; Antipsychotic Agents; Disulfiram; Humans; Motivation; Psychotherapy; | 1995 |
[Inpatient treatment of alcohol dependence].
Topics: Alcohol Deterrents; Alcoholism; Anti-Anxiety Agents; Benzodiazepines; Disulfiram; Ethanol; Hospitali | 1997 |
The integration of pharmacotherapy and nonpharmacotherapy.
Topics: Alcohol Deterrents; Behavior, Addictive; Combined Modality Therapy; Disease Susceptibility; Disulfir | 1997 |
Rational treatment of addiction.
Topics: Alcohol Deterrents; Alcoholism; Animals; Attitude; Disulfiram; Humans; Narcotic Antagonists; Narcoti | 1998 |
The meaning and treatment of alcohol dependence.
Topics: Alcohol Withdrawal Delirium; Alcoholic Beverages; Alcoholics Anonymous; Alcoholism; Amnesia; Aversiv | 1975 |
Modern methods in treatment of chronic alcoholism: a review of the Soviet literature.
Topics: Alcoholism; Aversive Therapy; Chronic Disease; Conditioning, Classical; Disulfiram; Electronarcosis; | 1976 |
Pharmacological treatment of alcohol intoxication, withdrawal and dependence: a critical review.
Topics: Alcohol Deterrents; Alcoholic Intoxication; Alcoholism; Antidepressive Agents, Tricyclic; Bromocript | 1987 |
[Chronic alcoholism. Development conditions and therapy].
Topics: Alcohol Oxidoreductases; Alcoholism; Autogenic Training; Chlormethiazole; Chronic Disease; Condition | 1972 |
43 other studies available for disulfiram and Substance Withdrawal Syndrome
Article | Year |
---|---|
Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Topics: Alcoholism; Cell Line, Tumor; Copper; Disulfiram; Glutathione; Humans; Nanoparticles; Substance With | 2022 |
[The Practice of Medicinal Alcohol Withdrawal in the Psychiatry of the GDR - The Methods of Aversion and Disulfiram Treatment].
Topics: Alcohol Deterrents; Alcoholism; Disulfiram; Germany; Humans; Psychiatry; Substance Withdrawal Syndro | 2022 |
Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.
Topics: Alcoholism; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disul | 2023 |
DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis.
Topics: Alcoholism; Amino Acid Transport System y+; Animals; Cell Line, Tumor; Copper; Disulfiram; Ditiocarb | 2023 |
Effect of lockdown following COVID-19 pandemic on alcohol use and help-seeking behavior: Observations and insights from a sample of alcohol use disorder patients under treatment from a tertiary care center.
Topics: Adult; Alcohol Deterrents; Alcoholic Beverages; Alcoholism; Coronavirus Infections; COVID-19; Disulf | 2020 |
Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Disulfiram; Male; Methadone; Mice; Mice, Inbred C57BL | 2018 |
Disulfiram--alcohol reaction mimicking an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Alcohol Deterrents; Alcoholism; Diagnosis, Differential; Disulfiram; | 2014 |
Long-term γ-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics.
Topics: Adult; Alcohol Deterrents; Alcoholics; Alcoholism; Disulfiram; Drug Therapy, Combination; Ethanol; F | 2011 |
Pharmacotherapy for adolescent alcohol use disorder.
Topics: Acamprosate; Adolescent; Alcohol-Related Disorders; Antidepressive Agents; Attention Deficit Disorde | 2012 |
[Esophageal rupture in alcohol withdrawal treatment with tetraethylthiuram disulfide].
Topics: Alcohol-Induced Disorders; Alcohols; Disulfiram; Esophagus; Psychoses, Substance-Induced; Rupture; S | 1957 |
MOTIVATION CONFLICTS OF THE ALCOHOL ADDICT.
Topics: Alcoholism; Calcium; Calcium, Dietary; Conditioning, Classical; Disulfiram; Ethanol; Humans; Imides; | 1964 |
PSYCHIATRIC ASPECTS OF ALCOHOLISM.
Topics: Alcoholism; Counseling; Disulfiram; Drug Therapy; Humans; Hypnosis; Lysergic Acid Diethylamide; Psyc | 1965 |
Drug treatment for alcoholism today.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Disulfiram; Fructose; Humans; Na | 2005 |
Changes in glutathione in acute and chronic alcohol intoxication.
Topics: Alcoholic Intoxication; Alcoholism; Animals; Disulfiram; gamma-Glutamyltransferase; Glutathione; Hum | 1980 |
[Role of GABA-ergic and dopaminergic mechanisms in the withdrawal syndrome after discontinuation of long-term phenazepam administration].
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Brain; Dihydr | 1980 |
Disulfiram encephalopathy as a cause of the catatonia syndrome.
Topics: Adult; Alcoholism; Catatonia; Disulfiram; Humans; Male; Substance Withdrawal Syndrome; Substance-Rel | 1980 |
Drug treatments for alcoholism.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Substance Withdrawal Sy | 2002 |
Ambulatory management in alcoholism.
Topics: Alcohol Drinking; Alcoholism; Ambulatory Care; Anti-Anxiety Agents; Antidepressive Agents; Benzodiaz | 1977 |
The use of psychoactive drugs in the long-term treatment of chronic alcoholics.
Topics: Alcoholism; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Chlordiazepoxide; Chlorpromazine; Ch | 1975 |
Multiple drug interactions with phenytoin.
Topics: Alcoholism; Disulfiram; Epilepsy; Female; Humans; Middle Aged; Phenytoin; Substance Withdrawal Syndr | 1977 |
[Drug therapy in ambulatory care of alcohol abuse].
Topics: Alcoholism; Ambulatory Care; Disulfiram; Humans; Psychotropic Drugs; Substance Withdrawal Syndrome; | 1978 |
[Therapy of alcoholism].
Topics: Acute Disease; Alcohol Withdrawal Delirium; Alcoholic Intoxication; Alcoholism; Avitaminosis; Chroni | 1976 |
Clinical features and treatment of alcoholism.
Topics: Alcohol Deterrents; Alcoholics Anonymous; Alcoholism; Ambulatory Care; Amines; Cyanides; Denial, Psy | 1977 |
Alcoholism: averaged visual evoked response amplitude-intensity slope and symmetry in withdrawal.
Topics: Adult; Alcoholism; Arousal; Disulfiram; Evoked Potentials; Functional Laterality; Humans; Male; Midd | 1976 |
[Abstinence behavior and plasma concentration of disulfiram in alcoholics after esperal implantation].
Topics: Adult; Alcoholism; Disulfiram; Drug Implants; Humans; Male; Middle Aged; Substance Withdrawal Syndro | 1976 |
Alcohol and its drug interactions.
Topics: Alcoholic Intoxication; Alcoholism; Barbiturates; Brain; Depression, Chemical; Disulfiram; Dose-Resp | 1975 |
A total community approach to the treatment of alcoholism.
Topics: Alcoholism; Community Health Centers; Community Health Services; Community Mental Health Services; D | 1975 |
[Electrolyte metabolism in alcoholic patients during therapy and prolonged abstinence].
Topics: Adrenal Cortex; Adrenal Insufficiency; Adult; Alcoholism; Apomorphine; Disulfiram; Erythrocytes; Hum | 1976 |
Drug therapy in alcoholism.
Topics: Adult; Alcoholic Intoxication; Alcoholism; Antidepressive Agents; Anxiety; Carbamates; Chlordiazepox | 1970 |
Drug therapy in alcoholism. It is especially important in the prevention of such complications as seizures, DT's, Wernicke's encephalopathy, or polyneuritis.
Topics: Alcoholism; Anticonvulsants; Chlordiazepoxide; Chlorpromazine; Diazepam; Disulfiram; Humans; Hydroxy | 1971 |
The biochemical pharmacology of abused drugs. II. Alcohol and barbiturates.
Topics: Alcohol Withdrawal Delirium; Alcoholism; Aldehyde Oxidoreductases; Alkaloids; Barbiturates; Chemical | 1974 |
[Therapy of alcoholics].
Topics: Alcoholism; Chlormethiazole; Disulfiram; Ethanol; Humans; Physician-Patient Relations; Psychotherapy | 1972 |
Alcoholism among methadone patients: a specific treatment method.
Topics: Alcohol Drinking; Alcoholism; Disulfiram; Heroin; Heroin Dependence; Hospitalization; Humans; Methad | 1973 |
[Therapy of alcoholism].
Topics: Alcoholism; Amines; Cyanides; Disulfiram; Humans; Psychotherapy; Psychotherapy, Group; Substance Wit | 1973 |
[Effect of withdrawal therapy on urinary excretion of 17-ketosteroids in male patients with chronic alcoholism].
Topics: 17-Ketosteroids; Adult; Alcohol Drinking; Alcoholism; Chronic Disease; Disulfiram; Humans; Insulin; | 1972 |
[Use of Pipolphen in complications due to disulfiram therapy].
Topics: Alcoholism; Disulfiram; Humans; Promethazine; Substance Withdrawal Syndrome | 1972 |
Helping alcoholics abstain: an implantable substance.
Topics: Alcohol Drinking; Alcoholism; Cannabis; Delayed-Action Preparations; Disulfiram; Heroin; Humans; Met | 1972 |
[Therapy of alcoholics in medical practice].
Topics: Alcoholism; Disulfiram; Humans; Methods; Substance Withdrawal Syndrome | 1970 |
[The treatment of alcoholism].
Topics: Alcoholism; Behavior Therapy; Chlormethiazole; Disulfiram; Germany, West; Humans; Physician-Patient | 1970 |
[On the problems of stationary alcohol withdrawal treatment in psychiatric hospitals].
Topics: Alcoholism; Czechoslovakia; Disulfiram; Germany, East; Hospitals, Psychiatric; Humans; Legislation, | 1967 |
[Remarks on the treatment of alcoholic withdrawal with animal charcoal].
Topics: Alcoholism; Charcoal; Disulfiram; Humans; Male; Substance Withdrawal Syndrome | 1968 |
Modification by disulfiram or methyltyrosine methylester (H 44-68) of abstinence symptoms in morphine-tolerant rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Depression, Chemical; Disulfiram; Dopamine; | 1968 |
[The so-called primitive drinker. A contribution to the typology of the alcoholic].
Topics: Adult; Aggression; Alcoholism; Disulfiram; Educational Status; Family; Humans; Intelligence; Male; P | 1969 |